Regulations.gov document
Determinations; Not Withdrawn From Sale for Reasons of Safety or Effectiveness: DELALUTIN…
Notice · FDA-2006-P-0089 · posted Jun 25, 2010
Key facts
| Document ID | FDA-2006-P-0089-0004 |
|---|---|
| Title | Determinations; Not Withdrawn From Sale for Reasons of Safety or Effectiveness: DELALUTIN (hydroxyprogesterone caproate) Injection, 125 Milligrams/Milliliter and 250 Milligrams/Milliliter |
| Document type | Notice |
| Subtype | N-Notice |
| Agency | FDA |
| Docket | FDA-2006-P-0089 |
| Posted | Jun 25, 2010 |
| Federal Register citation | 75 FR 36419 |
| FR document number | 2010-15416 |
| Effective date | Jun 25, 2010 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: